CASE REPORT
|
doi:10.20944/preprints202409.2145.v1
Subject:
Dermatology,
Medicine And Pharmacology
Keywords:
eczematous reaction; adverse drug reaction; selective RET inhibitor; Selpercatinib; glucocorticoid
Online: 26 September 2024 (16:44:59 CEST)